Smilez, filby and Twinvest
There are two critical issues here as I understand it;
1. Safety - a non-toxic formulation, not yet achieved, but I suspect one will be found.
2. Targeting tumours - I don't understand how one would get the nanoparticles to identify the target tumours. We need to bear in mind that while many melanoma tumours are on the surface, much cancer is far less accessible. Also, many cancer cells are very tiny to begin with, and these are the real bastards that can emerge later, when you find the cancer has come back. I've been very impressed by the potential of virotherapy, because of its capacity to seek out cancerous cells, including miniscule ones. So how would the nanoparticles know what to attack as they course through the bloodstream, finding their way through all the tiny capillaries to get to the diseased cells?
I'd be pretty sure that administration by injection would be the method.
But don't ask me for medical advice - my know-how stops at the common cold.
- Forums
- ASX - By Stock
- nanoparticles trigger tumor cells to destruct
Smilez, filby and TwinvestThere are two critical issues here as...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $54.31M |
Open | High | Low | Value | Volume |
2.4¢ | 2.4¢ | 2.2¢ | $12.59K | 542.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 487271 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 487271 | 0.022 |
4 | 1066532 | 0.021 |
11 | 1231001 | 0.020 |
7 | 1037236 | 0.019 |
5 | 2061668 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 200000 | 1 |
0.024 | 653235 | 4 |
0.025 | 1070470 | 10 |
0.026 | 291415 | 3 |
0.027 | 250000 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online